HLA Class II with Lupus Nephritis in Moroccan Patients

References

• Al-Motwee S, Jawdat D, Jehani GS, et al. (2013). Association of HLA-DRB1*15 and HLADQB1*06 with SLE in Saudis. Ann Saudi Med, 33(3),229–234.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Reveille JD, Moutsopoulos HM, et al. (1996). Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum, 39(11),1833–1839.
   PubMed Web of Science ®Google Scholar
• Atouf O, Benbouazza K, Brick C, et al. (2008). HLA polymorphism and early rheumatoid arthritis in the Moroccan population. Joint Bone Spine, 75(5),554–558.
   PubMed Web of Science ®Google Scholar
• Bolin K, Sandling JK, Zickert A, et al. (2013). Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.PLoS One, 8(12), e84450.
   PubMed Web of Science ®Google Scholar
• Borchers AT, Leibushor N, Naguwa SM, et al. (2012). Lupus nephritis: A critical review. Autoimmun Rev, 12(2),174–194.
   PubMed Web of Science ®Google Scholar
• Bouatba L, Bachir H, Ammouri W, et al. (2014). Lupus érythémateux systémique au Maroc: étude analytique monocentrique de 440 patients. 70e Congrès de la Société nationale française de médecine interne, Paris (La Villette), 10–12 décembre 2014; La Revue de médecine interne 35S A142.
   Google Scholar
• Ceccarelli F, Perricone C, Borgiani P, et al. (2015). Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype. J Immunol Res, 2015:745647.
   PubMed Web of Science ®Google Scholar
• Chung SA, Brown EE, Williams AH, et al. (2014). Genetics International Consortium for Systemic Lupus Erythematosus. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J Am Soc Nephrol, 25(12),2859–2870.
   PubMed Web of Science ®Google Scholar
• Cortes LM, Baltazar LM, Lopez-Cardona MG, et al. (2004). HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Human Immunol, 65, 1469–1476.
   PubMed Web of Science ®Google Scholar
• Cui Y, Sheng Y, Zhang X. (2013). Genetic susceptibility to SLE: Recent progress from GWAS. J Autoimmun, 41, 25–33.
   PubMed Web of Science ®Google Scholar
• El-Haj IM, Ismail AM, El-Halafawy KE, et al. (2014). Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Egyptians. IJAR, 2(7),831–838.
   Google Scholar
• Elhattab FZ, Essaadouni L. (2013). Incidence du lupus érythémateux systémique à Marrakech (Maroc). 67e congrès de la Société nationale franc¸ aise de médecine interne – 5, 6 et 7 juin 2013, Marseille /La Revue de médecine interne 34S: A105.
   Google Scholar
• El Sherbini HM, El Garf AK, El Din Mahmoud SS. (2009). Human leukocyte antigen and autoantibodies association with juvenile systemic lupus erythematosus. Egypt J Immunol, 16 (2),107–114.
   PubMedGoogle Scholar
• Endreffy E, Kovács A, Kovács L, Pokorny G. (2003). HLA class II allele polymorphism in Hungarian patients with systemic lupus erythematosus. Ann Rheum Dis, 62, 1017–1018.
   PubMed Web of Science ®Google Scholar
• Freedman BI, Spray BJ, Heise ER, et al. (1993). A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. Am J Kidney Dis, 21, 378–82.
   PubMed Web of Science ®Google Scholar
• Furukawa H, Kawasaki A, Oka S, et al. (2014). Human leukocyte antigens and systemic lupus erythematosus: A protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS One, 9 (2), e87792.
   PubMed Web of Science ®Google Scholar
• Giovanna G, Agnes BF. (2013). Lupus nephritis: Is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol, 8, 138–145.
   PubMed Web of Science ®Google Scholar
• Graham RR, Ortmann WA, Langefeld CD, et al. (2002). Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet, 71:543–555.
   PubMed Web of Science ®Google Scholar
• Haddiya I, Hamzaoui H, Tachfouti N, et al. (2013). Features and outcomes of lupus nephritis in Morocco: Analysis of 114 patients. Int J Nephrol Renovasc Dis, 6:249–258.
   PubMedGoogle Scholar
• Hahn BH, McMahon MA, Wilkinson A, et al. (2012). American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken), 64(6),797–808.
   PubMed Web of Science ®Google Scholar
• Kim K, Bang SY, Lee HS, et al. (2014). The HLA-DRbeta1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun, 5, 5902.
   PubMed Web of Science ®Google Scholar
• Li Y, Fang X, Li QZ. (2013). Biomarker profiling for lupus nephritis. Genomics Proteomics Bioinf, 11(3),158–165.
   PubMedGoogle Scholar
• Liphaus BL, Goldberg AC, Kiss MH, Silva CA. (2002). Analysis of human leukocyte antigens class II-DR in Brazilian children and adolescents with systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo, 57, 277–282.
   PubMedGoogle Scholar
• Logar D, Vidan-Jeras B, Dolzan V, et al. (2002). The contribution of HLA-DQB1 coding and QBP promoter alleles to anti-Ro alone autoantibody response in systemic lupus erythematosus. Rheumatology (Oxford), 41, 305.
   PubMed Web of Science ®Google Scholar
• Marchini M, Antonioli R, ALleò A, et al. (2003). HLA class II antigens assoiated with lupus nephritis in italian SLE patients. Human Immunol, 64(4),462–468.
   PubMed Web of Science ®Google Scholar
• Martín-Villa J, Martínez-Laso J, Moreno-Pelayo M, et al. (1998). Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: Role of TAP2*01 alleles in Ro autoantibody production. Ann Rheum Dis, 57, 214–219.
   PubMed Web of Science ®Google Scholar
• Mokbel AN, Al-Zifzaf DS, ElSawy WS, ElGabarty S. 2015). Association of HLA-DQB1∗06 with susceptibility to systemic lupus erythematosus in Egyptians. Egyptian Rheumatologist, 37(1),17–22.
   Google Scholar
• Mosaad YM, Hammad A, Youssef HM, Elhanbly S. (2010). HLA-DRB1*15 Confers susceptibility to juvenile SLE But is not associated with disease presentation: An Egyptian Study. Immunol Invest, 39, 235–244.
   PubMed Web of Science ®Google Scholar
• Ouadghiri S, El Alaoui TK, Brick C, et al. (2013). Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II. Pathol Biol (Paris), 61(6),259–263.
   PubMed Web of Science ®Google Scholar
• Pan CF, Wu CJ, Chen HH, et al. (2009). Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan. Lupus, 18, 698–704.
   PubMed Web of Science ®Google Scholar
• Pons-Estel GJ, Alarcon GS, Scofield L, et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum, 39(4),257–268.
   PubMed Web of Science ®Google Scholar
• Ramos PS, Brown EE, Kimberly RP, Langefeld CD. (2010). Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol, 30(2),164–176.
   PubMed Web of Science ®Google Scholar
• Sfar I, Dhaouadi T, Krichen H, et al. (2010). Genotyping CTLA-4 exon 1 (+49 A/G) and HLA-DRB1 polymorphisms and susceptibility to systemic lupus and rheumatoid arthritis in Tunisian population. J Med Genet Genomics, 2(1),008–017.
   Google Scholar
• Tazi-Mezalek Z, Harmouche H, Adnaoui M, et al. (2000). Particularités du lupus érythémateux disséminé au Maroc à propos de 166 observations. Rev Méd Interne, 21:465–466.
   PubMed Web of Science ®Google Scholar
• Vasconcelos C, Carvalho C, Leal B, et al. (2009). HLA in Portuguese systemic lupus erythematosus patients and their relation to clinical features. Ann N Y Acad Sci, 1173, 575–580.
   PubMed Web of Science ®Google Scholar
• Wadi W, Elhefny NE, Mahgoub EH, et al. (2014). Relation between HLA typing and clinical presentations in Systemic Lupus Erythematosus patients in Al-Qassim region, Saudi Arabia International J Health Sci, Qassim University, 85(2),160–165.
   Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, et al. (2004). The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol, 15(2),241–250.
   PubMed Web of Science ®Google Scholar
• Zhili N, Pingan Z, Yongqing T. (2015). Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: A meta-analysis. Int J Rheumatic Dis, 18, 17–28.
   PubMed Web of Science ®Google Scholar